Browse diseases

…Vascular dementia (VaD) is the second leading cause of dementia after Alzheimer’s…

…antibodies are the first disease-modifying therapies (DMTs) for Alzheimer’s disease (AD). Participants were excluded on MRI grounds if they had sev…

…nderpin their dual inheritance modes. We propose nine candidate AD/AR genes and emphasise caution in filtering by inheritance type…

…its effects on neurobiological changes in a scopolamine-induced AD model, combined with chronic neuropathic pain. The impact of tr…

…on-affective psychosis and depression may help reduce long-term dementia risk and inform prevention strategies.…

…Introduction Alzheimer’s disease (AD) is a neurodegenerative disorder that severely hinders qual…

…future symptom onset.Methods 20 asymptomatic autosomal dominant AD mutation carriers who performed normally on standard cognitive …

…rolled trials of patients with mild cognitive impairment due to Alzheimer’s disease (AD) or mild AD treated with mAB or AChEI for at least 6 months…

…nt for mild cognitive impairment (MCI) and mild dementia due to Alzheimer’s disease (AD) in adults who are apolipoprotein E ε4 gene (APOE4) heteroz…

…K inhibitors display distinct organ-specific safety profiles in AD management. This study establishes the first comparative safety…

…ith IBD have a higher risk of developing dementia, particularly AD.3 The ‘gut-brain axis’, which links the intestine and the centr…

…, cause endothelial cell dysfunction and play a role in driving portal hypertension and liver-related mortality. This study aimed to develop and va…